Locally delivered doxycycline hyclate: case selection, preparation, and application.
This article presents the perspective of a private practice clinician who participated in the phase III clinical trials of Atridox (doxycycline hyclate) 10%. The selection of periodontal cases most likely to benefit from treatment with Atridox as part of overall comprehensive case management is discussed. Atridox may be used either before or after scaling and root planing or, in more rare circumstances, as a stand-alone therapy. Preparation of the material is discussed, and guidance for optimal application is provided.
Bogle
G
G
Department of Periodontics, Loma Linda University, Loma Linda, California, USA.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000737:chemistry; D017326:Clinical Trials, Phase III as Topic; D003728:Dental Calculus / Q000628:therapy; D004318:Doxycycline / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000737:chemistry; D004339:Drug Compounding; D005891:Gingivitis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D010518:Periodontitis / Q000188:drug therapy*; D011182:Postoperative Care; D011331:Private Practice; D016745:Root Planing
D000900:Anti-Bacterial Agents; D004318:Doxycycline